Skip to main content
Premium Trial:

Request an Annual Quote

Kroger Prescription Plans to Offer Myriad Genetics' Vectra DA as Benefit Option

NEW YORK (GenomeWeb) -- Kroger Prescription Plans will provide the multi-marker rheumatoid arthritis test VectraDA as a benefit option for its employer group clients, Myriad Genetics announced today.

Rich Adams, senior VP of Kroger Prescription Plans, a pharmacy benefit management services provider, estimated that specialty drugs to treat autoimmune diseases like rheumatoid arthritis comprise 10 percent of pharmacy spending in the US. "Vectra DA has demonstrated the ability to improve patient outcomes while optimizing pharmaceutical spending which makes it a highly attractive diagnostic test for our members," Adams said in a statement.

Vectra DA gauges 12 biomarkers and measures rheumatoid arthritis disease activity. Researchers have published data showing that the test impacts doctor's treatment recommendations, helps improve patient's physical function, increases quality-adjusted life years, and decreases costs over 10 years.

According to Myriad, it is in late-stage discussions with Kroger Prescription Plans to implement a similar program for GeneSight, a pharmacogenetic test for selecting psychotropic drugs to which patients with major depressive disorder are most likely to respond.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.